Hematologic Disorders PNLE Questions

Introduction

The live Tangerine inventory contains exactly 35 original PNLE-style practice questions for Hematologic Disorders. Its canonical scope covers anemia, blood cancers when hematologic disease is primary, clotting disorders, and transfusion reactions. The practice decisions include recognizing impaired oxygen delivery or perfusion, identifying bleeding or clotting risk, protecting a patient with abnormal blood-cell counts, verifying transfusion safety, and responding promptly to a suspected reaction.

This topic stays focused on the hematologic problem and its nursing priorities. It excludes site-specific cancer care and acute shock or bleeding resuscitation, while Cancer Assessment and Diagnosis and Shock and Resuscitation remain adjacent topics for later mixed practice.

Hematologic Disorders is a Tangerine pedagogical lens within NP4: Medical-Surgical. It maps across relevant competencies in the official five-subject PNLE TOS and is not a separate official test subject. The 2025 Enhanced TOS assigns weights to broad competency areas, not a guaranteed number of questions for this microtopic or any particular exam form.

Key concepts

Connect anemia to oxygen delivery
Recognize: Fatigue, pallor, dizziness, dyspnea, reduced activity tolerance, or a change in vital signs can signal reduced oxygen delivery; bleeding history and clinical trends add context.
Decide: Assess oxygenation, circulation, symptoms, possible bleeding, and ordered results, then prioritize a change that threatens stability.
Avoid: Treating one symptom as proof of a single anemia type or selecting an intervention before assessing the patient.
Separate platelet, coagulation, and cell-count risks
Recognize: Petechiae, bruising, mucosal bleeding, prolonged bleeding, unusual clotting cues, or limb and respiratory changes point toward different safety concerns.
Decide: Match precautions and assessment to the established disorder, with attention to bleeding, thrombosis, perfusion, and changes from baseline.
Avoid: Assuming that every hematologic disorder creates the same risk or applying bleeding precautions without considering the full clinical picture.
Prioritize the primary hematologic disease
Recognize: Blood cancers may affect marrow function and circulating blood cells, creating concerns about anemia, infection, bleeding, fatigue, or treatment tolerance.
Decide: Focus the nursing assessment on the blood-cell problem, current symptoms, protection from complications, and prescribed monitoring.
Avoid: Importing site-specific solid-cancer surgery, staging, or symptom management into a question whose primary problem is hematologic.
Verify transfusion safety before administration
Recognize: The patient, order, product, identifiers, expiration information, access, and required verification must agree before the transfusion proceeds.
Decide: Stop the process and resolve any barcode, identification, order, or compatibility discrepancy according to institutional policy.
Avoid: Bypassing a failed barcode, relying on memory, or judging compatibility from the appearance of the blood product or line.
Respond to a suspected transfusion reaction
Recognize: New fever, chills, rash, respiratory symptoms, pain, or circulatory changes during or after transfusion require immediate attention, even before the exact reaction type is known.
Decide: Stop the transfusion, assess the patient, notify the appropriate team, and follow the reaction protocol for access, product handling, documentation, and further evaluation.
Avoid: Continuing the product while observing, restarting it independently, or delaying action until a definitive reaction label is available.
Use acuity and scope to set priority
Recognize: A sudden change during transfusion differs in urgency from stable chronic anemia or a preventive assessment of bleeding risk.
Decide: Address immediate threats to airway, breathing, circulation, or perfusion first, while staying within the hematologic decision being tested.
Avoid: Drifting into a full shock-resuscitation algorithm or site-specific cancer care when the question asks for a hematologic nursing action.

What to expect on the PNLE

The live inventory has 7 easy, 11 medium, and 17 hard questions. Its Bloom distribution is remembering=8, understanding=1, applying=7, analyzing=4, and evaluating=15. This supports preparation for decisions that require weighing competing cues, selecting a safe first response, and judging whether an action is appropriate, not only recalling disease descriptions.

Representative question forms include recognizing impaired peripheral perfusion in a blood disorder, selecting a key intervention for thrombocytopenia, identifying a likely transfusion complication, checking transfusion-line or product compatibility, and deciding what to do when verification fails. These forms require the learner to connect a cue with a nursing priority and to reject an unsafe shortcut.

Remembering and understanding: retrieve core distinctions among anemia, blood cancers, clotting disorders, and transfusion reactions, then explain why the cue matters.
Applying and analyzing: use the patient situation, timing, and safety information to choose an assessment or intervention and separate relevant from distracting details.
Evaluating: compare options for urgency, risk, authorization, and scope, especially when a transfusion symptom or verification problem is present.

The inventory describes available practice, not a forecast of an exam form. Exact topic distribution varies by exam form, and the official five-subject PNLE TOS does not guarantee a microtopic count for Hematologic Disorders.

Study tips

Begin with diagnostic practice. Work through the 35-question inventory without checking rationales first. Mark each response as a recognition, first-action, safety, or prioritization decision, and record whether the uncertainty involved anemia, blood cancer, clotting, or transfusion care.
Use focused retrieval by decision lane. Draw a comparison grid rather than rereading paragraphs.
Make this four-column grid:
Problem | Key cue | First nursing decision | Safety boundary
Anemia | oxygen-delivery symptoms | assess stability and cause | do not diagnose from one sign
Blood cancer | abnormal cell-function risks | monitor and protect from complications | do not switch to site-specific cancer care
Clotting disorder | bleeding or clot cues | protect against the dominant risk | do not assume all disorders have one risk
Transfusion reaction | new symptom during or after transfusion | stop and follow protocol | do not continue an unverified product
Review each rationale and error. For every missed or guessed item, write the decisive cue, the safest action, why the chosen option was unsafe, and the scope boundary that mattered. Separate knowledge gaps from failures to prioritize.
Retry at spaced intervals. Re-answer missed items later without looking at the explanation, then explain the decision aloud in one or two sentences. Update the grid when a new cue changes the action or safety boundary.
Finish with mixed timed practice. Combine hematologic questions with the adjacent topics of Cancer Assessment and Diagnosis and Shock and Resuscitation. After timing ends, classify errors by remembering, applying, analyzing, or evaluating rather than merely counting correct answers.

Common mistakes to avoid

Choosing a laboratory result without assessing the patient. Learners may treat a reported blood value as the entire answer. The correcting principle is to connect the result with oxygenation, circulation, symptoms, bleeding, trends, and the ordered clinical context.
Confusing low-platelet bleeding with every clotting disorder. Bruising or mucosal bleeding supports a bleeding-risk decision, while new perfusion or respiratory changes may signal another priority. Use the disorder named in the stem and the current cue instead of applying one precaution to every hematologic problem.
Waiting to identify the exact transfusion reaction before acting. A new symptom during transfusion is itself a safety cue. Stop the transfusion and begin assessment and notification according to protocol; classification can follow the immediate protective action.
Continuing after a verification failure. A barcode mismatch, uncertain identifier, or questionable line compatibility is not a minor documentation issue. Pause, keep the product from being administered, and resolve the discrepancy through the approved verification process.
Restarting or finishing a suspected reaction. Reassurance, a mild appearance, or an incomplete symptom pattern does not make continued administration safe. Do not restart or continue the product unless the authorized protocol permits it after evaluation.
Allowing adjacent-topic knowledge to replace the tested scope. A hematologic question may mention cancer or bleeding without asking for tumor-site care or full shock resuscitation. Anchor the answer to the primary blood disorder, the immediate nursing cue, and the action requested.

Try a question

A real Hematologic Disorders question from our bank. Give it a shot.

Medium

A 43-year-old man with sickle cell disease is being monitored for lower limb circulation. Which assessment finding would indicate effective peripheral perfusion?

A

Body temperature remains below 99°F.

B

Patient feels touch on the soles of the feet.

C

Patient's toes can move through a full range of motion.

D

Capillary refill time is less than 3 seconds.

Rationale

For a patient with sickle cell disease, monitoring for adequate peripheral perfusion is crucial because vaso-occlusive events and impaired blood flow can lead to tissue ischemia, especially in the extremities. Effective peripheral perfusion means that oxygenated blood is reaching the tissues efficiently.

Why D is Correct: Capillary refill time less than 3 seconds is a direct and objective measure of peripheral perfusion. This assessment evaluates how quickly blood returns to the capillaries after they are momentarily emptied by pressure. A refill time of less than 3 seconds in adults indicates that arterial blood flow is sufficient and tissue perfusion is effective. This quick bedside test can help identify circulatory adequacy in at-risk patients such as those with sickle cell disease.

Why the Other Options Are Incorrect:

Option	Rationale
A. Body temperature remains below 99°F	While fever can indicate infection or inflammation in sickle cell patients, temperature alone does not assess peripheral perfusion. Peripheral perfusion refers specifically to blood flow to the extremities, not systemic or core temperature.
B. Patient feels touch on the soles of the feet	Ability to feel touch assesses sensory nerve function, not perfusion. Nerve function may be preserved even if blood flow is compromised, so this does not directly indicate effective circulation.
C. Patient's toes can move through a full range of motion	Movement evaluates muscle and nerve integrity, not arterial blood supply. Full range of motion does not guarantee that tissue oxygenation in the extremities is adequate.

Underlying Concepts & Clinical Reasoning: Peripheral perfusion is assessed by objective physical findings like capillary refill, skin color, temperature of extremities, and presence of pulses. In sickle cell disease, microvascular occlusion is a common complication due to sickled red blood cells obstructing capillaries, so routine assessments should focus on these parameters. Interpreting perfusion findings promptly allows for early intervention and prevention of tissue damage.

Clinical Pearl: Remember, capillary refill is particularly sensitive in identifying decreased circulating volume or peripheral vasoconstriction before other signs like loss of pulses or cyanosis become evident. The 3-second rule is a classic quick check for adequate circulation and is emphasized in most Med-Surg review resources as an essential component of circulation assessment.

Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.